FIXX - Homology Medicines, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/2016
Total Revenue3,684--
Cost of Revenue47,94821,378-
Gross Profit-44,264-21,378-
Operating Expenses
Research Development-21,378.1545,694.997
Selling General and Administrative17,3008,2794,305.021
Non Recurring---
Others---
Total Operating Expenses65,24829,65710,000.018
Operating Income or Loss-61,564-29,657-10,000.018
Income from Continuing Operations
Total Other Income/Expenses Net4,349-3341,953.201
Earnings Before Interest and Taxes-61,564-29,657-10,000.018
Interest Expense---
Income Before Tax-57,215-29,991-8,046.817
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-57,215-29,991-8,046.817
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-57,215-29,991-8,046.817
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-57,215-29,991-8,046.817